Assess Safety and Efficacy of VAD044 in HHT Patients
Assess Safety and Efficacy of VAD044 in HHT Patients
Active, not recruiting · NCT05406362 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assess Safety and Efficacy of VAD044 in HHT Patients | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, arteriovenous hemangioma/malformation, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-17 | NCT05406362 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vaderis Therapeutics AG | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospices Civils de Lyon | Lyon | France | 43 |
| Hospital Universiati De Bellvitge | Barcelona | Spain | 1 |
| Hospital Universitario Ramón y Cajal | Madrid | Spain | 42 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Ospedale Maggiore di Crema | Crema | Italy | 1 |
| St. Antonius Hospital | Nieuwegein | Netherlands | 14 |
| Universitair Ziekenhuis Gent | Ghent | Belgium | 21 |